Molecular Chaperone Hsp90 as a Target for Oxidant-Based Anticancer Therapies

Beck R.; Dejeans N.; Glorieux C.; Calderon P.B.; Verrax J.; Pedrosa R.C.; Vosquez D.; Valderrama, J.A.

Keywords: stability, acid, proteins, oxygen, toxicity, therapy, animals, degradation, arsenic, kidney, protein, cell, liver, heat, stress, carcinoma, mechanism, cancer, quinone, humans, leukemia, human, agents, species, melanoma, oxidants, neoplasms, shock, anthraquinone, drug, molecular, article, kinase, heat-shock, destruction, prostate, imexon, antineoplastic, oncoprotein, chaperones, stat5, papillary, benzyl, trioxide, imatinib, trastuzumab, oxidative, derivative, coumarin, menadione, hsp90, nonhuman, Ascorbic, Reactive, unclassified, activated, lawsone, unindexed, buthionine, sulfoximine, mitogen, isothiocyanate, phenethyl, promyelocytic, geldanamycin, salazosulfapyridine, novobiocin, 90, bortezomib, adaphostin, alvespimycin, ansamycin, apatone, kf, 29163, ocx, 191, radicicol, sulforaphane, tanespimycin

Más información

Título según WOS: Molecular Chaperone Hsp90 as a Target for Oxidant-Based Anticancer Therapies
Título de la Revista: CURRENT MEDICINAL CHEMISTRY
Volumen: 18
Número: 18
Editorial: BENTHAM SCIENCE PUBL LTD
Fecha de publicación: 2011
Página de inicio: 2816
Página final: 2825
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-79959347917&partnerID=q2rCbXpz
Notas: ISI